the checkmate 816 trial: the success of adjuvant nsclc therapies - lung cancer onctalk 2022
Published 1 year ago • 155 plays • Length 12:35Download video MP4
Download video MP3
Similar videos
-
3:25
checkmate 816: neoadjuvant nivolumab chemotherapy for nsclc - onctalk lung 2023
-
8:13
checkmate 816: combining chemo and opdivo - asco lung review 2022
-
11:30
asco 2021 lung recap: surgical outcomes & checkmate 816: nivolumab in early stage nsclc
-
7:35
current treatments for oligometastatic nsclc - lung cancer onctalk 2022
-
3:22
discussing biomarkers and pd-l1 testing with your doctor - lung cancer onctalk 2022
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023
-
6:00
the adaura trial: 2023 updates - targeted therapies in lung cancer 2023
-
3:38
q&a: will all trials result in therapeutic changes? - onctalk lung 2023
-
1:15
gracecastuc-054_lung_wakelee: my approach to repeat biopsies for adv. nsclc with insufficient tissue
-
2:00
keynote 671: perioperative pembrolizumab for nsclc - onctalk lung 2023
-
11:48
asco lung cancer roundtable - nsclc trial updates: checkmate 9la opdivo and yervoy with chemo vs
-
2:22
q&a: what does monitoring look like after adjuvant chemotherapy? - onctalk lung 2023
-
2:43
pneumonectomy in nsclc - onctalk lung 2023
-
15:30
gracecast-020_lung-cancer_sarita dubey on early stage nsclc chemo
-
2:44
grace targeted therapies lung cancer 2021 -progression on tagrisso, amivantamab or better treatment?
-
3:02
the future of ret nsclc treatment - targeted therapies in lung cancer 2023
-
1:13
the alina trial for alk nsclc
-
2:32
segmentectomy for early stage nsclc - onctalk lung 2023